With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The initial consideration for the transaction is US$ 12 million
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The inspection was carried out between May 26, 2025 and May 31, 2025
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The Durezol brand and generic had US sales of approximately US $40 million MAT for the most recent twelve months ending in Nov 2022 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
